Drug Combination Details
| General Information of the Combination (ID: C45594) | |||||
|---|---|---|---|---|---|
| Name | Epigallocatechin gallate NP Info | + | Tapentadol Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Breast cancer
[ICD-11: 2C60]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Augmenting Drug Sensitivity | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vitro Model | MDA-MB-231 | CVCL_0062 | Breast adenocarcinoma | Homo sapiens | ||
| Experimental
Result(s) |
EGCG and TAP reduced the proliferation of MDA-MB-231 cells by impairing cell-cycle progression. | |||||